<--- Back to Details
First PageDocument Content
Nanotechnology / Neuroblastoma / Nanoparticle / Enhanced permeability and retention effect / Management of cancer / CRLX101 / Nanomedicine / Medicine / Oncology / Brain tumor
Date: 2015-05-03 15:44:22
Nanotechnology
Neuroblastoma
Nanoparticle
Enhanced permeability and retention effect
Management of cancer
CRLX101
Nanomedicine
Medicine
Oncology
Brain tumor

Nanoparticles may exploit tumor weaknesses to selectively attack cancers

Add to Reading List

Source URL: phys.org

Download Document from Source Website

File Size: 48,99 KB

Share Document on Facebook

Similar Documents

CRLX101 / Nanoparticle / Docetaxel / Organic chemistry / Nanotechnology / Nanomaterials / Chemistry

BioCentury, THE BERNSTEIN R EPORT

DocID: 1aVmt - View Document

Cancer treatments / Ovarian cancer / Cancer / Chemotherapy / CRLX101 / Management of cancer / Medicine / Oncology / Gynaecological cancer

Award ID: DP150091 Project Title: Selective Tumor Delivery of Anti-Cancer Agents in Ovarian Cancer Therapy Award Mechanism: Bridging the Gap: Early Translational Research Awards

DocID: 1a7Zy - View Document

Docetaxel / Ovarian cancer / Renal cell carcinoma / Metastasis / Antibody-drug conjugate / Cyclacel / Medicine / Bevacizumab / CRLX101

The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

DocID: 19brv - View Document

Nanotechnology / Neuroblastoma / Nanoparticle / Enhanced permeability and retention effect / Management of cancer / CRLX101 / Nanomedicine / Medicine / Oncology / Brain tumor

Nanoparticles may exploit tumor weaknesses to selectively attack cancers

DocID: 13Bwh - View Document

Nanomaterials / Nanoparticle / Nanotechnology / Ultraviolet radiation / CRLX101 / Trastuzumab / Chemotherapy / Breast cancer / Management of cancer / Medicine / Cancer treatments / Ribbon symbolism

active agent needs to enter the body, travel through the bloodstream to arrive at the tumour site, penetrate the tumour mass and then gain entry to

DocID: x8xs - View Document